Prognosis and survival for clear cell renal cell carcinoma, breast cancer and prostate cancer are linked with LPCAT1 expression; it is useful as a diagnostic biomarker for prostate and esophageal cancers. This evidence concerns the gene LPCAT1 and esophageal cancer.